[HTML][HTML] A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth …
The biosafety of gene therapy remains a crucial issue for both the direct and cell-mediated
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
[HTML][HTML] A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth …
II Salafutdinov, DZ Gatina, MI Markelova… - …, 2023 - ncbi.nlm.nih.gov
The biosafety of gene therapy remains a crucial issue for both the direct and cell-mediated
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA …
II Salafutdinov, DZ Gatina, MI Markelova… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The biosafety of gene therapy remains a crucial issue for both the direct and cell-mediated
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA …
II Salafutdinov, DZ Gatina, MI Markelova… - …, 2023 - search.ebscohost.com
The biosafety of gene therapy remains a crucial issue for both the direct and cell-mediated
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA …
II Salafutdinov, DZ Gatina, MI Markelova… - …, 2023 - search.proquest.com
The biosafety of gene therapy remains a crucial issue for both the direct and cell-mediated
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA …
II Salafutdinov, DZ Gatina, MI Markelova… - Biomedicines, 2023 - europepmc.org
The biosafety of gene therapy remains a crucial issue for both the direct and cell-mediated
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …
delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic …